Noam Zelcer Selected Research

Noam Zelcer Research Topics

Disease

6	Neoplasms (Cancer) 07/2018 - 11/2002
4	Atherosclerosis 01/2022 - 03/2006
4	Inflammation (Inflammations) 01/2022 - 03/2006
4	Breast Neoplasms (Breast Cancer) 05/2005 - 11/2002
3	Atherosclerotic Plaque (Atheroma) 01/2023 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2019
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 06/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 06/2012
3	Obesity 01/2018 - 01/2016
3	Cholestasis 04/2006 - 01/2003
2	Hyperlipidemias (Hyperlipidemia) 03/2023 - 01/2022
2	Hypercholesterolemia 01/2022 - 08/2011
2	Neuroinflammatory Diseases 11/2021 - 06/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 07/2018 - 01/2017
2	Neoplasm Metastasis (Metastasis) 07/2018 - 01/2017
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2022
1	Ischemia 01/2022
1	Fatty Liver 01/2022
1	Multiple Sclerosis 11/2021
1	Weight Gain 01/2021
1	Fibrosis (Cirrhosis) 10/2019
1	Non-alcoholic Fatty Liver Disease 10/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Carcinogenesis 01/2017
1	Insulin Resistance 01/2016
1	Dysequilibrium syndrome 12/2014
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2014
1	Vascular Diseases (Vascular Disease) 08/2014
1	LOM type hereditary motor and sensory Neuropathy 09/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2013
1	Dyslipidemias (Dyslipidemia) 08/2011
1	Glomerulonephritis 08/2009
1	Hyperplasia 07/2008
1	Memory Disorders (Memory Loss) 06/2008
1	Colonic Neoplasms (Colon Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

6	CholesterolIBA 11/2021 - 03/2006
5	LipidsIBA 01/2023 - 09/2013
5	Proteins (Proteins, Gene)FDA Link 07/2015 - 11/2002
5	multidrug resistance-associated protein 1IBA 05/2005 - 11/2002
4	ApolipoproteinsIBA 01/2022 - 06/2008
4	Liver X ReceptorsIBA 11/2021 - 06/2007
4	LDL Receptors (LDL Receptor)IBA 01/2020 - 06/2012
4	LDL CholesterolIBA 01/2020 - 08/2011
4	oxidized low density lipoproteinIBA 01/2019 - 08/2011
3	Bile Acids and Salts (Bile Acids)IBA 04/2006 - 01/2003
2	VLDL LipoproteinsIBA 01/2022 - 12/2014
2	Lipoproteins (Lipoprotein)IBA 01/2022 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2012 - 08/2011
2	GlucuronidesIBA 04/2006 - 01/2004
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2005 - 11/2002
2	Methotrexate (Mexate)FDA LinkGeneric 05/2005 - 08/2004
1	Amino Acids FDA Link 03/2023
1	Galectin 2 (LGALS2)IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Single-Domain AntibodiesIBA 01/2022
1	Galectins (Galectin)IBA 01/2022
1	Apolipoproteins B (ApoB)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Oleic Acid (Oleate)IBA 10/2019
1	elaidic acidIBA 10/2019
1	Alanine Transaminase (SGPT)IBA 10/2019
1	Trans Fatty AcidsIBA 10/2019
1	PalmitatesIBA 10/2019
1	Succinic Acid (Succinate)IBA 01/2018
1	Prorenin ReceptorIBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	TensinsIBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2016
1	LeptinIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	Cholesterol Esters (Cholesteryl Esters)IBA 07/2015
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2015
1	SubtilisinIBA 08/2014
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 08/2014
1	Liposomes (Liposome)IBA 08/2013
1	AntigensIBA 08/2013
1	AutoantibodiesIBA 08/2009
1	SterolsIBA 07/2008
1	GW 3965IBA 06/2008
1	multidrug resistance protein 3IBA 04/2006
1	coelenterazineIBA 06/2005
1	Renilla LuciferasesIBA 06/2005
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2005
1	Folic Acid AntagonistsIBA 08/2004
1	7-hydroxymethotrexateIBA 08/2004
1	BenzimidazolesIBA 08/2004
1	NU-ICRF 505IBA 01/2004
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2004
1	Topoisomerase I InhibitorsIBA 01/2004
1	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2004

Therapy/Procedure

1	Intravenous Injections 08/2013